We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available here.
Accept Cookies
CLINICAL PRACTICE GUIDELINES
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship
Learn More
NCCN GUIDELINES®|Learn More

March is Lymphedema Awareness Month

At ImpediMed, we’re committed to raising awareness about the importance of early detection and treatment of lymphedema, a potential side effect of breast cancer treatment that can significantly impact a patient’s quality of life. By working together, we can stop lymphedema before it becomes a chronic condition and help breast cancer survivors live their lives to the fullest.

SOZO® Digital Health Platform

Discover the SOZO Digital Health Platform, a groundbreaking advancement in early lymphedema detection and management. As the only FDA-cleared solution using bioimpedance spectroscopy (BIS), SOZO sets a new standard in breast cancer-related lymphedema care.

Download Product Brief

Interested in SOZO?

Discover how SOZO can support your lymphedema prospective care model. Our experts are ready to provide detailed information and assist with any questions.

Contact Us